Evidence map›Paper›PMID 35798529›Full record

ArticleBMJ open2022

Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol.

Amanda E Tanner, Tamar Goldenberg, Jennifer Toller Erausquin, Sulianie Mertus, Mohammed Sheikh Eldin Jibriel, Clare Barrington

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Stigmas experienced by sexual and gender minority people with HIV in the Dominican Republic: a qualitative study.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amanda E TannerDepartment of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA aetanner@uncg.edu.ORCID 0000-0003-4488-7160
Tamar GoldenbergDepartment of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA.
Jennifer Toller ErausquinDepartment of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA.ORCID 0000-0003-4271-6077
Sulianie MertusDepartment of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA.
Mohammed Sheikh Eldin JibrielDepartment of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA.
Clare BarringtonDepartment of Health Behavior, University of North Carolina, Chapel Hill, NC, USA.
University of North Carolina at Greensboro · USUniversity of North Carolina at Chapel Hill · US

Funding

POPULATION STUDIEST32HD007168 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ELIZABETH A FRANKENBERG · 1985 to 2026
$13.8M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
NICHD NIH HHS P2C HD050924NICHD NIH HHS T32 HD007168
6 · The paper itself

Abstract

introductionGlobally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic vulnerability and generates chronic stress. Anti-trans stigma occurs across multiple socioecological levels, resulting in multiple possible definitions and measurements of trans stigma. Understanding how trans stigma has been measured in low-income and middle-income countries (LMICs) is critical to health promotion efforts for trans communities. Accordingly, this scoping review will identify and examine how anti-trans stigma has been measured in existing LMIC-specific research to inform best practices for measurement of anti-trans stigma that includes consideration of local context. METHODS AND ANALYSIS: This is the protocol for a scoping review of anti-trans stigma in LMICs. We will search (from January 2001 to December 2021) PubMed, WHO Global Medicus and EBSCO. Study selection will conform to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Original studies in English, Spanish, Arabic or Russian will be included. Reviewers will independently screen all citations, full-text articles and abstract data. Data analysis will involve quantitative and qualitative methods. A narrative summary of findings will be conducted. ETHICS AND DISSEMINATION: As a scoping review (no direct interaction with participants), this study is exempt from human subjects oversight. Understanding context-specific ways to measure anti-trans stigma is urgently needed to support trans health globally. The planned scoping review will help to address this gap. Results of the review will be disseminated in a peer-reviewed journal and likely in other media such as conferences, seminars and symposia. PROTOCOL REGISTRATION NUMBER: osf.io/qcs2v.

Indexed as

Developing CountriesSocial StigmaTransgender PersonsFemaleHumansMaleResearch DesignScoping Reviews as TopicEDUCATION & TRAINING (see Medical Education & Training)MENTAL HEALTHPUBLIC HEALTH

Identifiers

PMID35798529
PMCPMC9263898
OpenAlexW4284688942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.